NS
Neelam Singh
About Neelam Singh
Data last updated:
Neelam Singh is a Director at Famn Pharma Private Limited (since 2019), Director at Zestoxy Pharma Private Limited (since 2022) and Director at Zestcare Pharma (Opc) Private Limited (since 2022). The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹16.45 Cr; the largest is Famn Pharma Private Limited at ₹10.73 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jul 2019 | 2019 | ₹10.73 Cr (FY 2025) | Active | |
| Director | 17 Feb 2022 | 2022 | ₹5.57 Cr (FY 2025) | Active | |
| Director | 09 Jun 2022 | 2022 | ₹15.9 Lakh (FY 2025) | Active |
Board colleagues of Neelam Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sunjeet Kumar Singh | 02749484 | Famn Pharma Private Limited , Zestoxy Pharma Private Limited and 1 more | Director |
| Devendra Girishbhai Singh | 09050943 | Zestcare Pharma (Opc) Private Limited | Nominee |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neelam Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neelam Singh
Neelam Singh currently holds 3 directorships: Famn Pharma Private Limited (Director, since 30 Jul 2019, revenue ₹10.73 Cr (FY 2025)); Zestoxy Pharma Private Limited (Director, since 17 Feb 2022, revenue ₹5.57 Cr (FY 2025)); Zestcare Pharma (Opc) Private Limited (Director, since 09 Jun 2022, revenue ₹15.9 Lakh (FY 2025)).
Neelam Singh was first appointed on 30 Jul 2019 as Director at Famn Pharma Private Limited. The most recent appointment on record is 09 Jun 2022 at Zestcare Pharma (Opc) Private Limited.
The 3 current companies of Neelam Singh that report revenue have a combined latest revenue of ₹16.45 Cr: Famn Pharma Private Limited ₹10.73 Cr (FY 2025); Zestoxy Pharma Private Limited ₹5.57 Cr (FY 2025); Zestcare Pharma (Opc) Private Limited ₹15.9 Lakh (FY 2025).
The current boards of Neelam Singh's companies include Sunjeet Kumar Singh (Famn Pharma Private Limited), Devendra Girishbhai Singh (Zestcare Pharma (Opc) Private Limited).